Exploratory Study of Upper and Lower Endoscopic Fuse System
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02651857 |
Recruitment Status :
Completed
First Posted : January 11, 2016
Last Update Posted : April 28, 2017
|
Sponsor:
EndoChoice Inc.
Information provided by (Responsible Party):
EndoChoice Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
Single-Center, Exploratory Study of EndoChoice's Upper and Lower Gastrointestinal Endoscopic Systems Utilizing EndoChoice's Full Spectrum Optical Technology
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Gastrointestinal Diseases | Device: Fuse® Colonoscope Device: Fuse® Gastroscope | Not Applicable |
The investigational devices are EndoChoice gastrointestinal endoscopic systems that are similar in their fit, form, and functions to the corresponding commercially available models with the exception of the EndoChoice's proprietary Optical system that enhances their field of view.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 1000 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Other |
Official Title: | Exploratory Study of Upper and Lower Endoscopic Fuse System |
Study Start Date : | November 2015 |
Actual Primary Completion Date : | April 27, 2017 |
Study Completion Date : | April 27, 2017 |
Arm | Intervention/treatment |
---|---|
Experimental: Endoscopy exploratory single arm |
Device: Fuse® Colonoscope
Endoscopic diagnostic procedures for lower GI tract Device: Fuse® Gastroscope Endoscopic diagnostic procedures for upper GI tract |
Primary Outcome Measures :
- Performance, usability and ease of use (performance questionnaire) [ Time Frame: Through study completion, estimate average of 1 year ]The performance of the device is assessed via a performance questionnaire which the recruiting (and treatment providing) physician will answer
Secondary Outcome Measures :
- Safety (adverse and severe adverse events) [ Time Frame: Through study completion, estimate average of 1 year ]Establish safety of the device by measure of adverse and severe adverse events, if such occur.
Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Male and Female patients ages of 18-75
- The patient has been scheduled for routine screening upper or lower endoscopy, diagnostic endoscopic work up, or endoscopic surveillance.
- Signed informed consent form
Exclusion Criteria:
- Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient's participation in this study.
- Patients who are unable to consent
- Pregnant female patients of any age.
No Contacts or Locations Provided
Responsible Party: | EndoChoice Inc. |
ClinicalTrials.gov Identifier: | NCT02651857 |
Other Study ID Numbers: |
Exploratory study |
First Posted: | January 11, 2016 Key Record Dates |
Last Update Posted: | April 28, 2017 |
Last Verified: | January 2016 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Additional relevant MeSH terms:
Gastrointestinal Diseases Digestive System Diseases |